Ontology highlight
ABSTRACT:
SUBMITTER: Carotenuto P
PROVIDER: S-EPMC8602334 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
Carotenuto Pietro P Amato Francesco F Lampis Andrea A Rae Colin C Hedayat Somaieh S Previdi Maria C MC Zito Domenico D Raj Maya M Guzzardo Vincenza V Sclafani Francesco F Lanese Andrea A Parisi Claudia C Vicentini Caterina C Said-Huntingford Ian I Hahne Jens C JC Hallsworth Albert A Kirkin Vladimir V Young Kate K Begum Ruwaida R Wotherspoon Andrew A Kouvelakis Kyriakos K Azevedo Sergio Xavier SX Michalarea Vasiliki V Upstill-Goddard Rosie R Rao Sheela S Watkins David D Starling Naureen N Sadanandam Anguraj A Chang David K DK Biankin Andrew V AV Jamieson Nigel B NB Scarpa Aldo A Cunningham David D Chau Ian I Workman Paul P Fassan Matteo M Valeri Nicola N Braconi Chiara C
Nature communications 20211118 1
FOLFIRINOX, a combination of chemotherapy drugs (Fluorouracil, Oxaliplatin, Irinotecan -FOI), provides the best clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients. In this study we explore the role of miRNAs (MIR) as modulators of chemosensitivity to identify potential biomarkers of response. We find that 41 and 84 microRNA inhibitors enhance the sensitivity of Capan1 and MiaPaCa2 PDAC cells respectively. These include a MIR1307-inhibitor that we validate in further PDAC cell l ...[more]